PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy

Cell Death and Disease

Volumn 6, Issue 5, 2015, Pages

  Wang, S C ^a   Li, Y H ^a   Piao, H L ^a   Hong, X W ^a   Zhang, D ^a   Xu, Y Y ^a   Tao, Y ^a   Wang, Y ^a   Yuan, M M ^a   Li, D J ^a   Du, M R ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD45RA ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR7; ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; LACTATE DEHYDROGENASE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN; T CELL IMMUNOGLOBULIN MUCIN 3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HAVCR2 PROTEIN, HUMAN; HEPATITIS A VIRUS CELLULAR RECEPTOR 2; MEMBRANE PROTEIN; PDCD1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DECIDUA; FEMALE; FETUS WASTAGE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPONTANEOUS ABORTION; TROPHOBLAST; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CBA MOUSE; GENETICS; IMMUNOLOGY; METABOLISM; REGULATORY T LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; DECIDUA; FEMALE; HEPATITIS A VIRUS CELLULAR RECEPTOR 2; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PREGNANCY; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTES, REGULATORY; TROPHOBLASTS; UP-REGULATION;

EID: 84951780803     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.112     Document Type: Article

References (38)

1. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993;151:4562-4573.
2. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 2007;29:95-113.
3. Renaud SJ, Cotechini T, Quirt JS, Macdonald-Goodfellow SK, Othman M, Graham CH. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J Immunol 2011;186:1799-1808.
4. Matthiesen L, Kalkunte S, Sharma S. Multiple pregnancy failures: an immunological paradigm. Am J Reprod Immunol 2012;67:334-340.
5. Moldenhauer LM, Hayball JD, Robertson SA. Utilising T cell receptor transgenic mice to define mechanisms of maternal T cell tolerance in pregnancy. J Reprod Immunol 2010;87:1-13.
6. Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med 2013;19:548-556.
7. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997;89:1818-1823.
8. Heemskerk MB, Roelen DL, Dankers MK, van Rood JJ, Claas FH, Doxiadis II et al. Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. Hum Immunol 2005;66:969-976.
9. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009;10:29-37.
10. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006;439:682-687.
11. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006;12:1198-1202.
12. Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 2009;83:9122-9130.
13. Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008;205:2763-2779.
14. Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 2010;107:14733-14738.
15. Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010;207:2187-2194.
16. McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM et al. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 2010;120:4546-4557.
17. Du MR, Guo PF, Piao HL, Wang SC, Sun C, Jin LP et al. Embryonic trophoblasts induce decidual regulatory T cell differentiation and maternal-fetal tolerance through thymic stromal lymphopoietin instructing dendritic cells. J Immunol 2014;192:1502-1511.
18. Guo PF, Du MR, Wu HX, Lin Y, Jin LP, Li DJ. Thymic stromal lymphopoietin from trophoblasts induces dendritic cell-mediated regulatory TH2 bias in the decidua during early gestation in humans. Blood 2010;116:2061-2069.
19. Burgers WA, Riou C, Mlotshwa M, Maenetje P, de Assis RD, Brenchley J et al. Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. J Immunol 2009;182:4751-4761.
20. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715.
21. Mittendorf EA, Storrer CE, Shriver CD, Ponniah S, Peoples GE. Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides. Breast Cancer Res Treat 2005;92:85-93.
22. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (∗). Annu Rev Immunol 2010;28:445-489.
23. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM et al. Differential distribution of CD4 (+) CD25 (bright) and CD8 (+) CD28 (-) T-cells in decidua and maternal blood during human pregnancy. Placenta 2006;27:S47-S53.
24. Blois SM, Joachim R, Kandil J, Margni R, Tometten M, Klapp BF et al. Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. J Immunol 2004;172:5893-5899.
25. Tilburgs T, Strominger JL. CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity. Am J Reprod Immunol 2013;69:395-407.
26. Shao L, Jacobs AR, Johnson VV, Mayer L. Activation of CD8+ regulatory T cells by human placental trophoblasts. J Immunol 2005;174:7539-7547.
27. Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 2010;120:4102-4110.
28. Zhou Q, Munger ME, Veenstra RG, Weigel BJ, Hirashima M, Munn DH et al. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood 2011;117:4501-4510.
29. Bengsch B, Martin B, Thimme R. Restoration of HBV-specific CD8+ T-cell function by PD-1 blockade in inactive carrier patients is linked to T-cell differentiation. J Hepatol 2014;66:1212-1219.
30. Wills MR, Okecha G, Weekes MP, Gandhi MK, Sissons PJ, Carmichael AJ. Identification of naive or antigen-experienced human CD8 (+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8 (+) T cell response. J Immunol 2002;168:5455-5464.
31. Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol 2011;32:345-349.
32. Gorman JV, Starbeck-Miller G, Pham NL, Traver GL, Rothman PB, Harty JT et al. Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection. J Immunol 2014;192:3133-3142.
33. Qiu Y, Chen J, Liao H, Zhang Y, Wang H, Li S et al. Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions. PLoS Pathog 2012;8:e1002984.
34. Kawahara H, Minami R, Yokota N. BAG6/BAT3: emerging roles in quality control for nascent polypeptides. J Biochem 2013;153:147-160.
35. O'Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010;327:1098-1102.
36. Perez-Mazliah D, Langhorne J. CD4 T-cell subsets in malaria: TH1/TH2 revisited. Front Immunol 2014;5:671.
37. Chabtini L, Mfarrej B, Mounayar M, Zhu B, Batal I, Dakle PJ et al. TIM-3 regulates innate immune cells to induce fetomaternal tolerance. J Immunol 2013;190:88-96.
38. Habicht A, Dada S, Jurewicz M, Fife BT, Yagita H, Azuma M et al. A link between PDL1 and T regulatory cells in fetomaternal tolerance. J Immunol 2007;179:5211-5219.